Abstract:Gastric carcinoma (GC) is one of the most common malignant tumors worldwide, and ranks fifth in incidence and top 5 in tumor-associated mortality. Unfortunately, the molecular mechanisms contributing to GC development are still unclear, urgently requiring more studies. It has been proposed that the multifunctional regulator receptor-interacting protein 2 (RIPK2) is both a regulator that induces stomach cancer and its complications such as cachexia. However, the potential molecular function of RIPK2 on regulation of GC is largely unknown. Moreover, 3,9-di-O-methylnissolin, a flavonoid derived from the roots of Astragalus membranaceus, exhibits protective effects against cancer, inflammation, and bacterial infections. Unfortunately the antineoplastic mechanism of oral exposure of such flavonoid are poorly understood. It remains unknown whether 3,9-di-O-methylnissolin is capable of mitigating GC progression, and potential molecular mechanism. This study aims to provide mechanistic evidence that the 3,9-di-O-methylnissolin-triggered mitigation of GC by repressing RIPK2 activity and its downstream ASK1 signaling. The TCGA database, GEO database, subjects with GC phenotype and GC cell lines were used in this work. 3,9-di-O-methylnissolin intervention reduces stomach cancer cell migration, proliferation and invasion in vitro. Also, 3,9-di-O-methylnissolin confers protection against tumor growth in xenograft model in vivo. Mechanistically, on the other hand, in the para-carcinoma tissue, overexpression of RIPK2 reduces lipogenesis and disturbs lipid homeostasis. Overexpression of RIPK2 activates downstream signaling of ASK1, which in turn downregulates PPARα, a master regulator of lipid metabolism. This process results in lower lipogenesis and downregulation of a set of PPARα target genes. Astragalus membranaceus naturally produces 3,9-di-O-methylnissolin, a bioactive substance that when suppression of ASK1 by methylnissolin reduces RIPK2-induced GC and its related cachexia and restores lipid homeostasis. These findings offer important new understandings of stomach cancer and could aid in the development of treatment plans for gastric carcinoma and cachexia related to cancer.

Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer

Abstract #1989: Down-regulation of Neuropilin-2 Suppresses in Vivo Growth of Gastric Cancer and Sensitizes Cells to 5Fu-Induced Apoptosis

Methylation of NRIP3 is a synthetic lethal marker for combined PI3K and ATR/ATM inhibitors in CRC

Methylation of NRIP3 is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.

RASSF1A Promotes ATM Signaling and RASSF1A Methylation is a Synthetic Lethal Marker for ATR Inhibitors.

NRAGE Promotes Cell Proliferation by Stabilizing PCNA in a Ubiquitin-Proteasome Pathway in Esophageal Carcinomas.

LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN

Methynissolin Confers Protection Against Gastric Carcinoma Via Targeting RIPK2

Methylation of TMEM176A, a Key ERK Signaling Regulator, is a Novel Synthetic Lethality Marker of ATM Inhibitor in Human Lung Cancer

Hypomethylated Gene NRP1 is Co-Expressed with PDGFRB and Associated with Poor Overall Survival in Gastric Cancer Patients.

RGS1 Serves As an Anti-Tumor Target to Inhibit Proliferation of NICN87-DR Cells and Tumor Growth in Gastric Cancer Mouse Model

NRAGE is Involved in Homologous Recombination Repair to Resist the DNA-damaging Chemotherapy and Composes a Ternary Complex with RNF8–BARD1 to Promote Cell Survival in Squamous Esophageal Tumorigenesis

Inhibition of APLN Suppresses Cell Proliferation and Migration and Promotes Cell Apoptosis in Esophageal Cancer Cells in Vitro, Through Activating PI3K/mTOR Signaling Pathway.

Inhibition of the Extracellular Signal-Regulated Kinase/mitogen-Activated Protein Kinase Pathway Decreases DNA Methylation in Colon Cancer Cells.

Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling

LOC441178 Overexpression Inhibits the Proliferation and Migration of Esophageal Carcinoma Cells via Methylation of miR-182

Biological Significance of 5-Aza-cdr on Methylation of BNIP3 Gene in Human Esophageal Carcinoma Cell Line Kyse-140

Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma

Arginine methylation of MTHFD1 by PRMT5 enhances anoikis resistance and cancer metastasis

Neuropilin 1 Expression Correlates with the Radio-resistance of Human Non-Small-cell Lung Cancer Cells

Silencing of Tumor-Suppressive NR_023387 in Renal Cell Carcinoma Via Promoter Hypermethylation and HNF4A Deficiency